Business Segments Laboratorios Richmond S.A.C.I.F.

Stocks

End-of-day quote Buenos Aires S.E. 14/08/2026			5-day change	1st Jan Change
1,555.00 ^ARS	+0.32%		+1.30%	-21.27%

06/08	Laboratorios Richmond S.A.C.I.F. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
11/05	Laboratorios Richmond S.A.C.I.F. announces Annual dividend, payable on May 15, 2026	CI

Breakdown by Business Segment (ARS)

Fiscal Period: December	2021	2022	2023	2024	2025
Private Market	591.4Cr	1.2TCr	3.26TCr	7.83TCr	10TCr
Gross Profit	327.56Cr	622.68Cr	1.85TCr	4.43TCr	6.57TCr
Net Income	29Cr	18Cr	-527.3Cr	1.34TCr	883.11Cr
Public Market - Others	301.94Cr	312.15Cr	496.54Cr	988.08Cr	1.96TCr
Gross Profit	106.21Cr	133.26Cr	176.75Cr	388.96Cr	891.04Cr
Net Income	14Cr	5.94Cr	-210.74Cr	91Cr	88Cr
Foreign Trade	46Cr	69Cr	141.81Cr	363.22Cr	621.51Cr
Gross Profit	21Cr	35Cr	30Cr	182.68Cr	362.31Cr
Net Income	84.89L	-20Cr	-58Cr	17Cr	101.44Cr
Public Market - Vaccines	722.46Cr	266.91Cr	-	-	-
Gross Profit	38Cr	82Cr	-	-	-
Net Income	-89.41L	-3.91Cr	-	-	-
Net Income	16Cr	16Cr	-288.72Cr	934.55Cr	-755.81Cr
Net Income	-	-	-	-	-8.04Cr
Public Market	-	-	-	-	-
Gross Profit	-	-	-	-	-
Net Income	-	-	-	-	-
Pharmaceutical Products
Pharmaceuticals	-	-	-	-	-
Interest Expense	-	-	-	-	-
Income Tax Expense	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
EBT	-	-	-	-	-
Gross Profit	-	-	-	-	-
D&A	-	-	-	-	-
Net Income	-	-	-	-	-

Geographical breakdown of sales (ARS)

Fiscal Period: December	2021	2022	2023	2024	2025
Argentina	1.56TCr	1.86TCr	4.01TCr	9.3TCr	13TCr
Foreign	66Cr	62Cr	126.21Cr	327.62Cr	555.96Cr
Unallocated Refund for Exports	-	-	-	-	-
Unallocated Granted Discounts	-	-	-	-	-
Unallocated Bonuses and Returns	-	-	-	-	-
Unallocated Gross Income Tax	-	-	-	-	-
Unallocated	-40Cr	-79Cr	-238.05Cr	-445.73Cr	-580.53Cr